The International Eosinophil Society (IES) is a global community of scientists and clinicians united in advancing understanding and treatment of eosinophil-related diseases, leading to improved patient outcomes and enhanced quality of life.
Take advantage of Early Registration Rates for the 2025 IES Congress by 1 May 2025!
Beyond the Bite: EoE and Food Allergy
Check out Beyond the Bite: EoE and Food Allergy—a powerful video raising awareness of eosinophilic gastrointestinal disorders and other rare diseases.
Watch here!
Membership Renewal Now Open for the 2025–2026 Term
*NEW* Regular Members get dual membership with EMBRN at no extra cost!
Free Early Career Memberships for pre-doctoral students, post-docs, clinical fellows & residents.
Single Cell Dissection of Human Mast Cells, Basophils and Eosinophils
Speakers:
Daniel Dwyer, PhD
Joakim Dahlin, PhD
Netali Ben-Baruch Morgenstern, PhD
Eosinophils in Check: The Promise of Benralizumab in EGPA Management
Reviewed by Federico Spataro & Antonio Giovanni Solimando, University of Bari, Italy
Eosinophils Under Fire: Benralizumab for Eosinophilic Asthma and COPD Exacerbations
Reviewed by Carlos Andrés Celis-Preciado, University of Sherbrooke, Canada
Explore the latest published research from the 2023 IES Congress, now available in the Journal of Leukocyte Biology. A comprehensive issue with these and more contributions is coming soon. Stay tuned for updates!
The 13th Biennial Congress of the International Eosinophil Society (IES) in 2025 will unite global experts to advance eosinophil research through cutting-edge sessions and collaborative discussions. Join us as we explore new frontiers in the field and strengthen global connections within the eosinophil research community.